Krebs Biochemicals and Industries Limited — Others, 08-08-2025: Copy of Newspaper Publication

Krebs Biochemicals & Industries Ltd has released its financial results for the quarter ended June 30, 2025, approved at a board meeting on August 7. The company reported total income from operations of ₹5.49 Cr, highlighting its revenue generation for the period. However, it posted a net loss of ₹5.32 Cr for the quarter, reflecting profitability challenges. Basic and diluted Earnings Per Share were ₹(2.47). These figures are key for shareholders to assess the company's recent operational and financial health.